Lufkin Industries Upgraded to “Outperform” at Wells Fargo (LUFK)

Wells Fargo upgraded shares of Lufkin Industries (NASDAQ: LUFK) from a market perform rating to an outperform rating in a research report sent to investors on Tuesday morning.

A number of other analysts have also recently weighed in on LUFK. Analysts at Barclays Capital cut their price target on shares of Lufkin Industries from $91.00 to $83.00 in a research note to investors on Friday, February 15th. They now have an overweight rating on the stock. Separately, analysts at Dahlman Rose downgraded shares of Lufkin Industries from a buy rating to a hold rating in a research note to investors on Monday, February 11th. They noted that the move was a valuation call. Finally, analysts at Zacks upgraded shares of Lufkin Industries from an underperform rating to a neutral rating in a research note to investors on Tuesday, January 29th. They now have a $59.40 price target on the stock.

Five investment analysts have rated the stock with a buy rating, five have assigned a hold rating, and one has given a sell rating to the stock. Lufkin Industries currently has an average rating of overweight and a consensus target price of $72.00.

Lufkin Industries opened at 64.98 on Tuesday. Lufkin Industries has a 1-year low of $45.11 and a 1-year high of $85.68. The stock’s 50-day moving average is currently $59.45. The company has a market cap of $2.168 billion and a price-to-earnings ratio of 26.52.

The company also recently announced a quarterly dividend, which is scheduled for Friday, March 8th. Investors of record on Friday, March 1st will be paid a dividend of $0.13 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Wednesday, February 27th.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows
Woman once on Death Row to Go Free
Woman once on Death Row to Go Free
Bidding for Back Bay Parking Spaces Reaches $560,000
Bidding for Back Bay Parking Spaces Reaches $560,000
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe